Because of its importance in vascular function, abnormal production of NO, as occurs in different disease states or following vascular injury, can adversely affect blood flow and other vascular functions. In addition to endothelial NOS, there is a neural NOS nNOS ; type I that serves as a transmitter in the brain and in different nerves of the peripheral nervous system, such as non-adrenergic, non-cholinergic NANC autonomic nerves that innervate penile erectile tissues and other specialized tissues in the body to produce vasodilation.
The activity of cNOS is calcium- and calmodulin-dependent. There are two basic pathways for the stimulation of cNOS, both of which involve release of calcium ions from subsarcolemmal storage sites. First, shearing forces acting on the vascular endothelium generated by blood flow causes a release of calcium and subsequent cNOS activation. Therefore, increases in blood flow stimulate NO formation flow-dependent NO formation.
Second, endothelial receptors for a variety of ligands stimulate calcium release and subsequent NO production receptor-stimulated NO formation. Included are receptors for acetylcholine M 3 muscarinic , bradykinin, substance-P, adenosine, and many others vasoactive substances. In the late s, Dr. Robert Furchgott observed that acetylcholine released a substance that produced vascular relaxation, but only when the endothelium was intact.
This observation opened this field of research and eventually led to his receiving a Nobel prize. Initially, Furchgott called this substance endothelium-derived relaxing factor EDRF , but by the mids he and others identified this substance as being NO. It differs, in part, from cNOS in that its activation is calcium independent.
Under normal, basal conditions, the activity of iNOS is very low. The activity of iNOS is stimulated during inflammation by bacterial endotoxins e. Most cells in the human body synthesise iNOS in response to inflammatory conditions. As all 3 isoforms of NOS are present either in the epidermal cells, dermal cells or both, skin can produce nitric oxide by an enzyme dependent mechanism. Human skin can release nitric oxide in an enzyme independent manner by UVA photolysis of nitric oxide stores.
Nitric oxide is also produced by reduction of sweat nitrate by skin commensal bacteria, in particular Staphylococci. Nitric oxide does not usually exist in its free form in the body due to its unstable nature but reacts with other molecules to form more stable products. Nitrate is the main storage form of nitric oxide. It is very stable when compared with other storage forms such as nitrites and RSNOs, which are important carriers and donor molecules of nitric oxide.
There are no tests for nitric oxide itself, as it is too unstable. Instead, nitrates, nitrites and nitrosylated compounds may be measured using the following tests. In the skin, insufficient nitric oxide may result in psoriasis by promoting cell proliferation and reducing differentiation of skin cells. Consuming food rich in nitrates and nitrites increases the level of nitric oxide and its storage form.
Just as deficiency of nitric oxide can lead to disease, too much can also cause disease. Nitric oxide is released from the cerebral vasculature, brain tissue and nerve endings.
In the skin, ultraviolet irradiation may lead to excessive nitric oxide production by enzyme-dependent and independent mechanisms. Nitric oxide has a role in the promotion and growth of melanoma via multiple mechanisms. Due to its antimicrobial properties, a nitric oxide-releasing gel formulation , berdazimer sodium SB, SB, Novan , is under evaluation to treat dermatophyte fungal infections such as tinea pedis and viral skin infections including genital warts and molluscum contagiosum.
See smartphone apps to check your skin. DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice. Revised October Nitric oxide — codes and concepts open. Nitrogen monoxide. Other inflammatory disorder. Free radical, Nitric oxide synthase - neuronal, endothelial and inducible, Nitrates, Role in the skin, Pollutant, Nitric oxide deficiency, Excessive nitric oxide, Role in skin disease.
Methods in Nitric Oxide Research. John Wiley and Sons, Weller R. Nitric oxide: a key mediator in cutaneous physiology. Clin Exp Dermatol. PubMed Weller R. Nitric oxide--a newly discovered chemical transmitter in human skin. Br J Dermatol. Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res. PubMed Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology.
Free Radic Res. The role of nitric oxide in melanoma. Biochim Biophys Acta Rev Cancer. A phase 2, controlled, dose-ranging study of SB, an investigational topical nitric oxide-releasing drug, for the treatment of tinea pedis. J Drugs Dermatol.
0コメント